Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $86.4 million.

  • Healthequity's Shares Outstanding (Weighted Average) fell 91.29% to $86.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $86.4 million, marking a year-over-year decrease of 91.29%. This contributed to the annual value of $86.9 million for FY2025, which is 152.63% up from last year.
  • Healthequity's Shares Outstanding (Weighted Average) amounted to $86.4 million in Q4 2025, which was down 91.29% from $86.6 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Shares Outstanding (Weighted Average) registered a high of $87.2 million during Q4 2024, and its lowest value of $74.2 million during Q1 2021.
  • Over the past 5 years, Healthequity's median Shares Outstanding (Weighted Average) value was $85.3 million (recorded in 2023), while the average stood at $84.6 million.
  • In the last 5 years, Healthequity's Shares Outstanding (Weighted Average) soared by 1539.61% in 2021 and then tumbled by 91.29% in 2025.
  • Healthequity's Shares Outstanding (Weighted Average) (Quarter) stood at $83.6 million in 2021, then grew by 1.22% to $84.6 million in 2022, then rose by 1.33% to $85.7 million in 2023, then increased by 1.75% to $87.2 million in 2024, then fell by 0.91% to $86.4 million in 2025.
  • Its last three reported values are $86.4 million in Q4 2025, $86.6 million for Q3 2025, and $86.7 million during Q2 2025.